Extension of DG ESIC Rate Contract No. Homoeo-3 · U-16013/101/2022-AYUSH-Part(1)
ESIC circular U-16013/101/2022-AYUSH-Part(1) · 08 Jan 2026
Official title
Extension of DG ESIC Homoeopathic Rate Contract No. Homoeo-3 (English)
Official record
Open source pageSummary
Check the official recordWhat changed
The Director General of ESIC extends the validity of the Homoeopathic Rate Contract No. Homoeo-3. The extension applies from 23 December 2025 to 22 February 2026. The contract remains valid until the finalization of a new rate contract if that occurs earlier. Medical Superintendents and Directors must ensure the supplying firm agrees to the original terms and conditions. Authorities must not place orders for drugs identified as Not of Standard Quality. Supply orders must go only to first preference holders. Officials must consider all previous amendments and orders related to the items or firms under this contract when they place new supply orders.
What you must do
- Confirm the willingness of the firm to supply on existing terms.
- Do not place orders for drugs found Not of Standard Quality.
- Place supply orders only to first preference holders.
Document text
File No. U-16013/101/2022-AYUSH-Part(1) Date: 07.01.2026 To, The Deans - All PGIMSR / ESIC Medical College & Hospitals The Medical Superintendent – All ESIC Hospitals The Director (Medical) Delhi/Noida The Director, ESI Scheme –All States Regional Director - All States Subject: Extension of DG ESIC Rate Contract No. Homoeo-3 issued vide file No. U-16/13/6/1/Homeo-3/2022-AYUSH dated 23.02.2023. Madam/Sir, I am hereby directed to inform the approval of Director General ESIC for extension of existing DG ESIC Rate Contract No. Homoeo-3 w.e.f 23.12.2025 to 22.02.2026 (earlier extended from 23.02.2025 to 22.04.2025, 23.04.2025 to 22.06.2025, 23.06.2025 to 22.09.2025 & 23.09.2025 to 22.12.2025) or till the finalization of the new Rate Contract, whichever is earlier subject to the following terms & conditions: 1.Willingness of the firm to supply on the same terms and conditions as approved in rate contract No. Homoeo-3. 2.No order should be placed in respect of drugs, which have been found "Not of Standard Quality" on test analysis. 3.Supply order should be placed only to first preference holders. 4.Amendments /orders (if any) already issued time to time in r/o items /firms of Rate Contract no. Homoeo-3 to be taken into consideration while placing the supply orders. This is for your kind information and further necessary action. This is issued with approval Competent Authority Yours Sincerely,
(Dr. Pawan Kumar) DMC (AYUSH) Copy to: U-16013/101/2022-AYUSH-Part(1) I/3447417/2026
- PPS / PS to DG, FC, MC (Ayush)
- Account Branch V, ESIC Hqrs Office
- Zonal Medical Commissioners (North, South, East, West, Northeast)
- Website Content Manager for uploading on ESIC website U-16013/101/2022-AYUSH-Part(1) I/3447417/2026
Source details
- Source
- Employees' State Insurance Corporation
- Type
- circular
- Published by source
- 08 Jan 2026
- Document number
- U-16013/101/2022-AYUSH-Part(1)
- Effective date
- 23 Dec 2025
- Coverage area
- labour